LIGAND PHARMACEUTICALS INCORPORATED Proceeds from Sale of Intangible Assets
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Proceeds from Sale of Intangible Assets of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfIntangibleAssets · last filed 2022-02-28
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from sale of intangible assets for the quarter ending 2020-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from sale of intangible assets for the quarter ending 2020-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from sale of intangible assets for the quarter ending 2020-06-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from sale of intangible assets for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from sale of intangible assets for fiscal 2021 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from sale of intangible assets for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from sale of intangible assets for fiscal 2019 was $812.80M.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from sale of intangible assets for fiscal 2018 was $0.00.
| Period end | Proceeds from Sale of Intangible Assets 3 month | Proceeds from Sale of Intangible Assets 6 month | Proceeds from Sale of Intangible Assets 9 month | Proceeds from Sale of Intangible Assets 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $0.00 10-Q · filed 2020-08-07 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $812.80M 10-K · filed 2022-02-28 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $812.80M 10-Q · filed 2020-11-06 | $812.80M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $812.80M 10-Q · filed 2020-08-07 | $812.80M derived: sum of 3 quarters · filed 2021-02-24 | $812.80M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $812.80M 10-Q · filed 2020-05-08 | $812.80M derived: sum of 2 quarters · filed 2021-02-24 | $812.80M derived: sum of 3 quarters · filed 2021-02-24 | $812.80M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $0.00 derived: sum of 2 quarters · filed 2021-02-24 | $0.00 derived: sum of 3 quarters · filed 2021-02-24 | $0.00 10-K · filed 2021-02-24 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 |